Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D003866', 'term': 'Depressive Disorder'}, {'id': 'D001008', 'term': 'Anxiety Disorders'}], 'ancestors': [{'id': 'D019964', 'term': 'Mood Disorders'}, {'id': 'D001523', 'term': 'Mental Disorders'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'D011613', 'term': 'Psychotherapy'}], 'ancestors': [{'id': 'D004191', 'term': 'Behavioral Disciplines and Activities'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 90}}, 'statusModule': {'overallStatus': 'RECRUITING', 'startDateStruct': {'date': '2023-10-10', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2024-10', 'completionDateStruct': {'date': '2025-12', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2024-10-31', 'studyFirstSubmitDate': '2024-10-10', 'studyFirstSubmitQcDate': '2024-10-31', 'lastUpdatePostDateStruct': {'date': '2024-11-04', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2024-11-04', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2025-12', 'type': 'ESTIMATED'}}, 'outcomesModule': {'otherOutcomes': [{'measure': 'Clinical Global Impressions - Severity of Illness (CGI-S)', 'timeFrame': 'Pre-post, through study completion, an average of 3 to 4 months', 'description': "Clinical impressions of the clinician's view on the client's global functioning, the overall severity of symptoms (CGI-S) Minimum score: 1 Maximum score: 7 A higher score indicates more severe impairment/worse outcome"}, {'measure': "Patient's Global Impressions of Severity (PGI-S)", 'timeFrame': 'Pre-post, through study completion, an average of 3 to 4 months', 'description': 'As CGI-S, the PGI-S is a 1-item global impression questionnaires that allow patients to report their own views on the severity of ongoing symptoms based on a 7-point scale Minimum score: 1 Maximum score: 7 A higher score indicates more severe impairment/worse outcome'}, {'measure': 'Clinical Global Impressions - Improvement (CGI-I)', 'timeFrame': 'Through study completion, an average of 3 to 4 months', 'description': "Clinical impressions of the client's improvement level that the client shows throughout the therapy (CGI-I) Minimum score: 1 Maximum score: 7 A lower score indicates better outcome"}, {'measure': 'Patient Global Impressions - Improvement (PGI-I)', 'timeFrame': 'Through study completion, an average of 3 to 4 months', 'description': 'PGI-S is a 1-item global impression questionnaires that allow patients to report their own views on the response and improvement to intervention based on a 7-point scale Minimum score: 1 Maximum score: 7 A lower score indicates better outcome'}, {'measure': 'Patient Attitudes with and Satisfaction towards Measurement-Based Care (PAS-MBC)', 'timeFrame': 'Through study completion, an average of 3 to 4 months', 'description': "A 12-item tailored questionnaire was created to fully capture clients' attitudes towards and experience with measurement-based care during their treatment.\n\nMinimum value: 12 Maximum value: 60 Higher score indicates better outcome/more positive attitudes toward measurement-based care"}], 'primaryOutcomes': [{'measure': 'Brief Adjustment Scale-6 (BASE-6)', 'timeFrame': 'Completed weekly through study completion, an average of 3 to 4 months', 'description': 'Self-report questionnaire designed to measure general psychological adjustment and functioning of adult-aged individuals Minimum score: 6 Maximum score: 42 A higher score indicates severe difficulty in psychological adaptation and functioning/worse outcome'}, {'measure': 'Patient Health Questionnaire-9 (PHQ-9)', 'timeFrame': 'Completed weekly through study completion, an average of 3 to 4 months', 'description': 'Evaluate depression symptoms Minimum score: 0 Maximum score: 27 A higher score indicates more severe depression/worse outcome'}, {'measure': 'Generalized Anxiety Disorder-7 (GAD-7)', 'timeFrame': 'Completed weekly through study completion, an average of 3 to 4 months', 'description': 'evaluate anxiety symptoms Minimum score: 0 Maximum score: 21 A higher score indicates more severe anxiety/worse outcome'}], 'secondaryOutcomes': [{'measure': 'World Health Organization Quality of Life-Brief (WHOQOL-BREF)', 'timeFrame': 'Pre-post, through study completion, an average of 3 to 4 months', 'description': "This is a self-report measure designed to assess an individual's quality of life and well-being across four domains, including physical health, psychological well-being, social relationships, and environmental conditions Minimum score: 0 Maximum score: 100 A higher score indicates a higher quality of life/better outcome"}, {'measure': 'Working Alliance Inventory-Short Form Revised (WAI-SR)', 'timeFrame': 'Completed monthly, through study completion, an average of 3 to 4 months', 'description': 'The WAI-SR is a self-report measure of the strengths of the therapeutic alliance that clients perceive.\n\nMinimum score: 12 Maximum score: 60 A higher score indicates a stronger working alliance between the provider and the patient / better outcome'}, {'measure': 'Vanderbilt Psychotherapy Process Scale - Patient version (VPPS)', 'timeFrame': 'Completed every 6 weeks; through study completion, an average of 3 to 4 months', 'description': 'The VPPS-P is a patient-report measure consisting of 42 items with five subscales, including therapist exploration, negative relationship, patient psychic distress, patient participation, therapist warmth and friendliness, and patient dependency.\n\nMinimum score: 42 Maximum score: 210 A higher score indicates better outcome'}]}, 'oversightModule': {'isUsExport': False, 'oversightHasDmc': False, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ['measurement-based care', 'effectiveness', 'RCT', 'implementation', 'psychotherapy', 'mechanisms of change'], 'conditions': ['Depressive Disorder', 'Anxiety Disorders']}, 'descriptionModule': {'briefSummary': "Although measurement-based care (MBC) is an evidence-based practice with known benefits, it is not always systematically implemented with fidelity. Questions remain regarding MBC's unique added value compared to usual care.\n\nThus, the goal of this clinical trial is to investigate the implementation outcome, effectiveness, and mechanisms of change of measurement-based care in adult behavioral health. This study implemented MBC in adult ambulatory behavioral health and will test outcomes using a pragmatic randomized control trial within the RE-AIM (Reach, Efficacy, Adoption, Implementation, and Maintenance) framework.\n\nResearchers will compare three groups: 1) the Measurement-based care group, 2) the treatment-as-usual group, and 3) the waitlist control group. Participants will participate in weekly individual psychotherapy sessions for 12 sessions in total.", 'detailedDescription': "Measurement-based care (MBC) is an evidenced-based practice, involving routine completion of patient-reported outcome measures and collaborative discussions between clinician and client to inform clinical decision-making and facilitate improvement. Despite its known benefits, such as reduced dropout rates and improved treatment outcomes, questions remain regarding MBC's unique effectiveness compared to standard care. Furthermore, mechanisms of change on how MBC actually works in treatment have yet to be fully investigated. Thus, the current study aims to conduct a randomized control trial to evaluate the added value of MBC, by comparing an MBC+psychotherapy group, a psychotherapy-only group, and a waitlist group with no interventions."}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n1. Primary concern and referral reason for seeking psychotherapy are either depressive- or anxiety-related symptoms and/or psychological distress, using minimum scores as follows: PHQ-9 (score \\> 4), GAD-7 (score \\> 4), and BASE-6 (score \\> 18), and\n2. being 18 years old or older.\n\nExclusion Criteria:\n\n1. Severe physical or psychiatric conditions that would hinder the treatment (e.g., clients with acute psychosis, intellectual disability, or neurocognitive disorders who do not have the capacity to undergo informed consent and participate in the study);\n2. currently receiving psychotherapy through another source;\n3. significant suicidal/homicidal risk that would need immediate intervention;\n4. do not have ability complete Patient-Rated Outcome Measures (PROMs) either in person or remotely'}, 'identificationModule': {'nctId': 'NCT06671158', 'acronym': 'MBC', 'briefTitle': 'Measurement-Based Care (MBC) Implementation, Effectiveness, and Mechanisms of Change', 'organization': {'class': 'OTHER', 'fullName': 'Carilion Clinic'}, 'officialTitle': 'An Evaluation of the Effectiveness and Mechanisms of Change of Measurement Based Care for Depressive and Anxiety Disorders', 'orgStudyIdInfo': {'id': 'IRB-23-1992'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Measurement-based care group', 'description': 'Measurement-based care group', 'interventionNames': ['Behavioral: Psychotherapy']}, {'type': 'ACTIVE_COMPARATOR', 'label': 'Treatment-as-Usual group', 'description': 'Treatment-as-Usual group', 'interventionNames': ['Behavioral: Psychotherapy']}, {'type': 'NO_INTERVENTION', 'label': 'Waitlist control group', 'description': 'Waitlist control group'}], 'interventions': [{'name': 'Psychotherapy', 'type': 'BEHAVIORAL', 'description': 'Individual psychotherapy for weekly 12-sessions', 'armGroupLabels': ['Measurement-based care group', 'Treatment-as-Usual group']}]}, 'contactsLocationsModule': {'locations': [{'zip': '24018', 'city': 'Roanoke', 'state': 'Virginia', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': "Virginia O'Brien, MD", 'role': 'CONTACT', 'email': 'vcobrien@carilionclinic.org', 'phone': '540-529-9603'}], 'facility': 'Carilion Mental Health', 'geoPoint': {'lat': 37.27097, 'lon': -79.94143}}], 'centralContacts': [{'name': 'Anita Kablinger, MD', 'role': 'CONTACT', 'email': 'askablinger@carilionclinic.org', 'phone': '540-527-4875'}], 'overallOfficials': [{'name': "Virginia O'Brien, MD", 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Carilion Clinic'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'UNDECIDED', 'description': 'Due to the need to protect patient confidentiality and privacy regarding identifiable health data'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Carilion Clinic', 'class': 'OTHER'}, 'collaborators': [{'name': 'Virginia Polytechnic Institute and State University', 'class': 'OTHER'}], 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'Principal Investigator', 'investigatorFullName': "Virginia O'Brien", 'investigatorAffiliation': 'Carilion Clinic'}}}}